Ahmad Awada is Head of the Oncology Medicine Department at Jules Bordet Cancer Institute Brussels, Belgium.
Professor Ahmad Awada was born in Lebanon and studied Medicine at the Université Libre de Bruxelles (ULB), Belgium. He did a specialisation in Internal Medicine and Medical Oncology at Jules Bordet Institute, in Brussels, until 1992. During his specialisation, he also followed trainings in the clinical development of new anticancer drugs. As a research fellow, he stayed in the Netherlands (New Drug Development Office, Free University, Amsterdam) and in San Antonio, USA (Institute for Drug Development). He focused on the clinical development of new anticancer agents.
Back from the USA at the beginning of 1994, Dr Awada became Assistant Head of the Medical Oncology Clinic, and Head of the New Drugs Development Unit at Jules Bordet Institute, Brussels. Since April 2005, he is the Head of the Medical Oncology Clinic. In July 2017, Dr Awada was appointed Head of Oncology Medicine Department at Jules Bordet Institute. He has an important clinical activity in the treatment of solid tumours and in particular breast cancer. Dr Awada took an active part in the development of new drugs (cytotoxics, molecular-targeted therapies, immunotherapy), some of them already widely used.
Dr Awada is member of several international scientific societies (ASCO, EORTC, ESMO), Professor of Clinical Medicine and Medical Oncology at the Université Libre de Bruxelles and he is also co-founder of Oncodistinct network for oncology research. He is a member of the ESMO Clinical Research Observatory Task Force, and the ESMO/ASCO Global Curriculum Working Group. He was previously the Faculty Coordinator for the ESMO Faculty Group Principles of Clinical Trials and Systemic Therapy. He has published 32 book chapters and 335 peer-reviewed articles in international publications.
Last update: June 2021